ULCERATIVE COLITIS CHRONIC
Clinical trials for ULCERATIVE COLITIS CHRONIC explained in plain language.
Never miss a new study
Get alerted when new ULCERATIVE COLITIS CHRONIC trials appear
Sign up with your email to follow new studies for ULCERATIVE COLITIS CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gut bacteria tested as potential treatment for bowel disease
Disease control Recruiting nowThis early-stage study is testing the safety and effects of an oral probiotic called R-3750 in adults with mild to moderate ulcerative colitis. Researchers will monitor side effects and check if the probiotic reduces bowel inflammation and improves symptoms. The goal is to see if…
Matched conditions: ULCERATIVE COLITIS CHRONIC
Phase: PHASE1 • Sponsor: Rise Therapeutics LLC • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New combo therapy trial offers hope for Tough-to-Treat bowel disease
Disease control Recruiting nowThis study is testing two new drugs, eltrekibart and mirikizumab, alone and together, for adults with moderate to severe ulcerative colitis. The goal is to see if these treatments can safely bring the disease under control and help patients achieve remission. It is for people who…
Matched conditions: ULCERATIVE COLITIS CHRONIC
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
3-Year trial tests Long-Term relief for kids with severe bowel disease
Disease control Recruiting nowThis study aims to see how well and how safely the drug mirikizumab works over a long period (about 3 years) in children and adolescents with moderate-to-severe ulcerative colitis or Crohn's disease. It is an extension study for about 150 young people who have already been taking…
Matched conditions: ULCERATIVE COLITIS CHRONIC
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC